These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10073324

  • 1. Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine.
    Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM.
    J Clin Pharmacol; 1999 Mar; 39(3):252-9. PubMed ID: 10073324
    [Abstract] [Full Text] [Related]

  • 2. Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance.
    Denaro CP, Wilson M, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 1996 Mar; 59(3):284-96. PubMed ID: 8653991
    [Abstract] [Full Text] [Related]

  • 3. Effect of venlafaxine on the pharmacokinetics of terfenadine.
    Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM.
    Psychopharmacol Bull; 1998 Mar; 34(3):383-9. PubMed ID: 9803772
    [Abstract] [Full Text] [Related]

  • 4. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
    Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, Kuranari M, Miyakawa I, Nakano S.
    Clin Pharmacol Ther; 2001 Aug; 70(2):121-5. PubMed ID: 11503005
    [Abstract] [Full Text] [Related]

  • 5. The effect of liver disease on urine caffeine metabolite ratios.
    Denaro CP, Wilson M, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
    [Abstract] [Full Text] [Related]

  • 6. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF, Yi T, Cao XM, Zhuo HT, Ling SS.
    Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
    [Abstract] [Full Text] [Related]

  • 7. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, Rüsing G, Labedzki A, Bulitta J, Sörgel F.
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [Abstract] [Full Text] [Related]

  • 8. Effect of venlafaxine on the pharmacokinetics of risperidone.
    Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM.
    J Clin Pharmacol; 1999 Mar; 39(3):297-309. PubMed ID: 10073330
    [Abstract] [Full Text] [Related]

  • 9. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B, Sáenz MA, Lanuza J, Bernal ML, Fanlo A, Juste JL, Mayayo E.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [Abstract] [Full Text] [Related]

  • 10. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M, Pontes ZB, Gueguen R, Galteau MM, Siest G.
    Genet Epidemiol; 1994 Feb; 11(2):115-29. PubMed ID: 8013893
    [Abstract] [Full Text] [Related]

  • 11. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
    Tang BK, Zhou Y, Kadar D, Kalow W.
    Pharmacogenetics; 1994 Jun; 4(3):117-24. PubMed ID: 7920691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X, Lee WY, Or PM, Yeung JH.
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pantoprazole lacks induction of CYP1A2 activity in man.
    Hartmann M, Zech K, Bliesath H, Steinijans VW, Koch H, Wurst W, Mascher H.
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):159-64. PubMed ID: 10235417
    [Abstract] [Full Text] [Related]

  • 18. Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis.
    Lelouët H, Bechtel YC, Paintaud G, Brientini MP, Miguet JP, Bechtel PR.
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):25-32. PubMed ID: 11204934
    [Abstract] [Full Text] [Related]

  • 19. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS, Fuhr U.
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [Abstract] [Full Text] [Related]

  • 20. A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.
    Levin GM, Nelson LA, DeVane CL, Preston SL, Eisele G, Carson SW.
    Psychopharmacol Bull; 2001 Aug; 35(2):62-71. PubMed ID: 12397887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.